New York City, NY -- (SBWIRE) -- 01/08/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Epizyme Inc (NASDAQ:EPZM), LiveDeal Inc (NASDAQ:LIVE), Verso Paper Corp. (NYSE:VRS)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) gained 89.69%, trading on 18.98 million shares, to end the trade at $18.51. The stock changed hands in a range of $15.20 to $18.62, bringing its market capitalization to about $1.25 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $8.08 and was moved to the maximum level of $18.62. Neurocrine Biosciences, Inc. (Neurocrine) discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders. The Company’s product candidates address some of the pharmaceutical markets including endometriosis, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.
For How Long NBIX will fight for Profitability? Read This Trend Analysis report
Epizyme Inc (NASDAQ:EPZM) added 75.56%, to complete the trading session at $35.99, with a total volume of 3.81 million shares. The stock, on average, trades on a volume of 223,637 shares. It floated in a range of $31.02 to $37.69 during the last trading session. Its market capitalization now moved to about $1.02 billion. In the past 52 weeks, the share price has not declined below $18.10 and above $45.72. Epizyme, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers. The Company systematically identify the genetic alterations that create cancer causing genes, called oncogenes, select patients in whom the identified genetic alteration is found and then design small molecule therapeutics to inhibit the oncogene.
For How Long EPZM Gloss will Attract Investors? Find out via this report
LiveDeal Inc (NASDAQ:LIVE) recorded a gain of 64.04% and was in a range of $5.80-$9.37 before closing at $9.35. The stock completed the day with a total volume of 1.59 million shares, versus an average volume of 85,454 shares. The share price hit its 52-week low of $1.97 and $9.37 was the best price. LiveDeal, Inc. provides web-based local customer acquisition and related products for small and local businesses. The Company's website is ideal for trading hard-to-ship items such as automobiles, furniture, pets, appliances, real estate and other "try before you buy" items, eliminating shipping costs and reducing fraud.
Will LIVE Continue To Move Higher? Find Out Here
Verso Paper Corp. (NYSE:VRS) added 36.45% yesterday, bringing its market capitalization around $232.90 million. The share price, after opening at $3.55, made a high of $5.55 and hovered above $3.50 to end the day at $4.38. The total number of shares that changed hands during the session was 12.84 million shares, as compared to average trading volume of 254,355 shares. Verso Paper Corp. (Verso Paper) is a holding company. Verso Paper is engaged in producer of coated freesheet, coated groundwood, and uncoated supercalendered papers. These products are used in catalogs, magazines, retail inserts, and commercial print.
Why Should Investors Buy VRS After The Recent Gain? Just Go Here and Find Out
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)